| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 310,100 | 282,100 | 248,000 | 246,900 | | Cost of Revenue | 250,600 | 267,900 | 243,900 | 193,000 | | | Gross Profit | 59,500 | 14,200 | 4,100 | 53,900 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 47,300 | 30,800 | 35,700 | 34,900 | | Non Recurring |
-
| 5,300 | (5,300) | (300) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,300 | (21,900) | (26,300) | 19,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,100 | 100 |
-
| 700 | | Earnings Before Interest And Taxes | 21,300 | (21,800) | (26,300) | 20,000 | | Interest Expense | 10,600 | 10,300 | 9,700 | 9,200 | | Income Before Tax | 10,700 | (32,100) | (36,000) | 10,800 | | Income Tax Expense | 2,200 | (10,300) | (9,400) | 3,600 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,500 | (21,800) | (26,600) | 7,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,500 | (21,800) | (26,600) | 7,200 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,500 | ($21,800) | ($26,600) | $7,200 |
|
1.52% Nasdaq 0.00%
Income Statement
